These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1419295)

  • 1. Tumour burden as the main indicator of prognosis in Hodgkin's disease.
    Specht L
    Eur J Cancer; 1992; 28A(12):1982-5. PubMed ID: 1419295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour burden in early stage Hodgkin's disease: the single most important prognostic factor for outcome after radiotherapy.
    Specht L; Nordentoft AM; Cold S; Clausen NT; Nissen NI
    Br J Cancer; 1987 May; 55(5):535-9. PubMed ID: 3300762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors in Hodgkin's disease stage III with special reference to tumour burden.
    Specht L; Nissen NI
    Eur J Haematol; 1988 Jul; 41(1):80-7. PubMed ID: 3402591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hodgkin's disease and age.
    Specht L; Nissen NI
    Eur J Haematol; 1989 Aug; 43(2):127-35. PubMed ID: 2792320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor cell concentration and tumor burden in relation to histopathologic subtype and other prognostic factors in early stage Hodgkin's disease. The Danish National Hodgkin Study Group.
    Specht L; Lauritzen AF; Nordentoft AM; Andersen PK; Christensen BE; Hippe E; Hou-Jensen K; Nissen NI
    Cancer; 1990 Jun; 65(11):2594-601. PubMed ID: 2337876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors in Hodgkin's disease stage IV.
    Specht L; Nissen NI
    Eur J Haematol; 1988 Oct; 41(4):359-67. PubMed ID: 3197822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes over the course of time in histological subclassification of Hodgkin's disease in Denmark.
    Lauritzen AF; Specht LK; Nissen NI; Hou-Jensen K
    Dan Med Bull; 1991 Feb; 38(1):84-7. PubMed ID: 2026054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor burden as the most important prognostic factor in early stage Hodgkin's disease. Relations to other prognostic factors and implications for choice of treatment.
    Specht L; Nordentoft AM; Cold S; Clausen NT; Nissen NI
    Cancer; 1988 Apr; 61(8):1719-27. PubMed ID: 3349432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Independent prognostic impact of tumour-infiltrating macrophages in early-stage Hodgkin's lymphoma.
    Gotti M; Nicola M; Lucioni M; Fiaccadori V; Ferretti V; Sciarra R; Costanza M; Bono E; Molo S; Maffi A; Croci GA; Varettoni M; Frigeni M; Pascutto C; Arcaini L; Bonfichi M; Paulli M; Cazzola M
    Hematol Oncol; 2017 Sep; 35(3):296-302. PubMed ID: 27060262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infiltration of eosinophils in Hodgkin's disease involved lymph nodes predicts prognosis.
    Enblad G; Sundstrom C; Glimelius B
    Hematol Oncol; 1993; 11(4):187-93. PubMed ID: 8144133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A rare nasopharyngeal tumor: Hodgkin's disease].
    Strutz J; Zöllner C; Wannenmacher M; Mann W
    Laryngol Rhinol Otol (Stuttg); 1988 Jan; 67(1):38-40. PubMed ID: 3347135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of primary site after radiotherapy in non-Hodgkin's lymphomata.
    Musshoff K; Schmidt-Vollmer H
    Br J Cancer Suppl; 1975 Mar; 2():425-34. PubMed ID: 1101929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The T and B lymphocyte content of lymph nodes and spleen in Hodgkin's disease.
    Stathopoulos G; Papamichail M; Peckham MJ; Davies AJ; Holborow EJ
    Br J Exp Pathol; 1977 Dec; 58(6):712-6. PubMed ID: 305255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: long-term follow-up and patterns of failure.
    Liao Z; Ha CS; Vlachaki MT; Hagemeister F; Cabanillas F; Hess M; Tucker S; Cox JD
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):971-7. PubMed ID: 11429225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
    Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of the number of involved areas in the early stages of Hodgkin's disease.
    Tubiana M; Henry-Amar M; Hayat M; Burgers M; Qasim M; Somers R; Sizoo W; Van der Schueren E
    Cancer; 1984 Sep; 54(5):885-94. PubMed ID: 6378359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multivariate analysis of prognostic factors in early stage Hodgkin's disease.
    Tubiana M; Henry-Amar M; van der Werf-Messing B; Henry J; Abbatucci J; Burgers M; Hayat M; Somers R; Laugier A; Carde P
    Int J Radiat Oncol Biol Phys; 1985 Jan; 11(1):23-30. PubMed ID: 3881375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour-associated mast cells in classical Hodgkin's lymphoma: correlation with histological subtype, other tumour-infiltrating inflammatory cell subsets and outcome.
    Andersen MD; Kamper P; Nielsen PS; Bendix K; Riber-Hansen R; Steiniche T; Hamilton-Dutoit S; Clausen M; d'Amore F
    Eur J Haematol; 2016 Mar; 96(3):252-9. PubMed ID: 25963595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hodgkin's disease: staging and treatment.
    Wagner HP
    Helv Paediatr Acta; 1986 Aug; 41(3):169-72. PubMed ID: 3759480
    [No Abstract]   [Full Text] [Related]  

  • 20. Follicular dendritic cells have prognostic relevance in Hodgkin's disease.
    Alavaikko MJ; Blanco G; Aine R; Lehtinen T; Fellbaum C; Taskinen PJ; Sarpola A; Hansmann ML
    Am J Clin Pathol; 1994 Jun; 101(6):761-7. PubMed ID: 8209866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.